B48.2
Allescheriasis
Clinical Classification Guidelines
Inclusion Terms
- Infection due to Pseudallescheria boydii
Excludes Type 1
- eumycetoma (B47.0)
Medical Intelligence & Overview
Allescheriasis is a rare fungal infection caused by the fungus Pseudallescheria boydii. This condition can affect various parts of the body, especially in individuals with weakened immune systems. Recognizing the symptoms and understanding the causes of this infection are essential steps toward managing the condition effectively. Although uncommon, Allescheriasis warrants attention due to its potential to cause significant health issues if left untreated.
Causes & Symptoms
Clinical Causes: Infection with the fungus Pseudallescheria boydii, which is found in soil, polluted water, and decaying organic matter. Exposure to contaminated environments, especially in immunocompromised individuals or those with open wounds. Inhalation of fungal spores, leading to respiratory infections. Inoculation through skin wounds or punctures contaminated with soil or environmental debris. Pre-existing health conditions that impair immune response, such as cancer, diabetes, or organ transplantation.
Key Symptoms: Fever and chills, particularly if the infection becomes systemic. Respiratory symptoms like cough, shortness of breath, or chest pain if lungs are affected. Skin lesions, including ulcers, nodules, or abscesses that may be tender or painless. Signs of systemic infection, such as fatigue, malaise, or weight loss. In severe cases, signs of disseminated infection affecting multiple organs.
Diagnostic & Treatment
Diagnosis Path: Imaging studies, such as X-rays or CT scans, to identify affected tissues. Laboratory analysis of tissue biopsies or fluid samples to observe fungal elements under a microscope. Culturing the organism from clinical specimens to confirm the presence of Pseudallescheria boydii. Serological tests or molecular techniques like PCR for detecting fungal DNA, supporting the diagnosis.
Treatment Protocols: Antifungal drugs such as amphotericin B, voriconazole, or itraconazole. Surgical intervention to remove necrotic tissue or drain abscesses if necessary. Supporting therapies for underlying health conditions to improve immune response. Monitoring for side effects of antifungal medications and adjusting treatment accordingly. Follow-up assessments to ensure the infection resolution and prevent recurrence.
Clinical Advice & FAQs
Billing Guidance
Is B48.2 a billable ICD-10 code?
Yes, B48.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B48.2?
Clinical documentation must specify the nature of Allescheriasis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
